These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8989590)

  • 1. Mechanisms of interference with the MHC class I-restricted pathway of antigen presentation by herpesviruses.
    Hill AB
    Immunol Cell Biol; 1996 Dec; 74(6):523-6. PubMed ID: 8989590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpesviruses placating the unwilling host: manipulation of the MHC class II antigen presentation pathway.
    Zuo J; Rowe M
    Viruses; 2012 Aug; 4(8):1335-53. PubMed ID: 23012630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpesviruses and immunity: the art of evasion.
    Griffin BD; Verweij MC; Wiertz EJ
    Vet Microbiol; 2010 Jun; 143(1):89-100. PubMed ID: 20303681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes viral proteins manipulating the peptide transporter TAP.
    Reits E; Griekspoor A; Neefjes J
    Curr Top Microbiol Immunol; 2002; 269():75-83. PubMed ID: 12224517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral evasion of the MHC class I antigen-processing machinery.
    Loch S; Tampé R
    Pflugers Arch; 2005 Dec; 451(3):409-17. PubMed ID: 16086162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploiting human herpesvirus immune evasion for therapeutic gain: potential and pitfalls.
    Horst D; Ressing ME; Wiertz EJ
    Immunol Cell Biol; 2011 Mar; 89(3):359-66. PubMed ID: 21301483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral interference with antigen presentation.
    Yewdell JW; Hill AB
    Nat Immunol; 2002 Nov; 3(11):1019-25. PubMed ID: 12407410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpesvirus homologues of cellular genes.
    Raftery M; Müller A; Schönrich G
    Virus Genes; 2000; 21(1-2):65-75. PubMed ID: 11022790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MHC class I antigen presentation pathway: strategies for viral immune evasion.
    Hewitt EW
    Immunology; 2003 Oct; 110(2):163-9. PubMed ID: 14511229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpesviruses and the microbiome.
    Dreyfus DH
    J Allergy Clin Immunol; 2013 Dec; 132(6):1278-86. PubMed ID: 23611298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention and therapy of herpesvirus infections].
    Abb J
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mouse TAP by immune evasion molecules encoded by non-murine herpesviruses.
    Verweij MC; Ressing ME; Knetsch W; Quinten E; Halenius A; van Bel N; Hengel H; Drijfhout JW; van Hall T; Wiertz EJ
    Mol Immunol; 2011 Mar; 48(6-7):835-45. PubMed ID: 21292324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells are susceptible to human herpesviruses, but viral DNA cannot be detected in the healthy seropositive individual.
    Sundin M; Orvell C; Rasmusson I; Sundberg B; Ringdén O; Le Blanc K
    Bone Marrow Transplant; 2006 Jun; 37(11):1051-9. PubMed ID: 16604097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious Triggers of Cytokine Storm Syndromes: Herpes Virus Family (Non-EBV).
    Dulek D; Thomsen I
    Adv Exp Med Biol; 2024; 1448():211-225. PubMed ID: 39117817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpesviruses hijack host exosomes for viral pathogenesis.
    Sadeghipour S; Mathias RA
    Semin Cell Dev Biol; 2017 Jul; 67():91-100. PubMed ID: 28456604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Masters of deception: a review of herpesvirus immune evasion strategies.
    Davis-Poynter NJ; Farrell HE
    Immunol Cell Biol; 1996 Dec; 74(6):513-22. PubMed ID: 8989589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The herpesvirus stealth program.
    Huang T; Osterrieder N
    Oncotarget; 2015 Sep; 6(26):21761-2. PubMed ID: 26335280
    [No Abstract]   [Full Text] [Related]  

  • 18. Viral interference with MHC class I antigen presentation pathway: the battle continues.
    Ambagala AP; Solheim JC; Srikumaran S
    Vet Immunol Immunopathol; 2005 Aug; 107(1-2):1-15. PubMed ID: 15978672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interference with antigen processing by viruses.
    Hengel H; Koszinowski UH
    Curr Opin Immunol; 1997 Aug; 9(4):470-6. PubMed ID: 9287180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegaloviral control of MHC class I function in the mouse.
    Hengel H; Reusch U; Gutermann A; Ziegler H; Jonjic S; Lucin P; Koszinowski UH
    Immunol Rev; 1999 Apr; 168():167-76. PubMed ID: 10399073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.